Clinical Trial

A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Evaluation Compared with traditional NACT, whether PIPAC can increase the incidence of CRS3 determines the rationality of choosing PIPAC.
Protocol Amendment History 2 changes
critical Phase changed: not applicable -> Phase 3 2026-05-12
minor Trial arms changed: 1 -> 2 2026-05-12
Trial Details
NCT Number NCT07544030
Lead Sponsor tongweihua
Conditions Ovarian Cancer
Enrollment 60 participants
Start Date 2025-11-10
Primary Completion 2027-11-10 (estimated)
Study Completion 2027-11-10 (estimated)
Updated on ClinicalTrials.gov 2026-05-11